In this commentary, Stanford tobacco expert Robert Jackler adds context to the recent decision by JUUL to stop direct social media in the U.S.
A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.
Across the country, states with more restrictive firearm laws have significantly fewer pediatric gun deaths than those with lax gun laws.
A Stanford-led study examines whether the Patient Activation Measure can serve as an early indicator that an effort is affecting health care costs
Stanford pain specialist argues for comprehensive and personalized treatments as Congress considers legislation to combat the opioid crisis.
Despite strong medical evidence, a California bill to delay school start times is defeated. But Stanford sleep specialist Rafael Pelayo isn’t giving up.
Nearly 500 children remain inside detention centers along the U.S.-Mexico border separated from their parents in the custody of the U.S. government.
Kenneth Gibbs, Jr., is using his graduate degree in immunology to improve graduate education nationally — he shares more in this Q&A.
A Lancet commission has found that poor quality health care causes millions of unnecessary deaths; the worst deficits were found in vulnerable populations.
Scientists review the compliance of pharmacies and tobacco-selling policies, finding that Walgreens is the most likely to sell to minors.
A study's comprehensive analysis reveals the indirect child casualties due to warfare in Africa; their deaths far outweigh direct warfare deaths.
Even substantial efforts in reducing opioid addiction, preventing overdoses and providing addiction treatment won't curb the crisis any time soon.
This Stars of Stanford Medicine Q&A features Satoshi Maruyama, a Japanese official in the health ministry who is earning a graduate degree at Stanford.
Black men are more likely to get follow up care and to mention other health concerns after visiting a black doctor, a new Stanford study has found.
Targeted screening can cut hepatitis B related deaths in the U.S. by half - and save money.
Children aren’t getting access to many new medical devices, but the U.S. Food and Drug Administration is working to change that.